12The carboxyl-terminal domain (CTD) of RNA polymerase II is involved in (A) binding to promoter regions of DNA. (B) formation of the transcription bubble. (C) coordinating post-transcriptional processing events. (D) recognition of the term nination signal. (E) None of the above.

12The carboxyl-terminal domain (CTD) of RNA polymerase II is involved in
(A) binding to promoter regions of DNA.
(B) formation of the transcription bubble.
(C) coordinating post-transcriptional processing events.
(D) recognition of the term nination signal.
(E) None of the above.

答案：登入後查看
統計： 尚無統計資料

詳解 (共 1 筆)

木公的診間裝潢中

B1 · 2024/01/19

#6012137

The carboxyl-termina...

(共 135 字，隱藏中）

前往觀看

9 Rifampicin is known to inhibit RNA synthesis in E. coli. Once the first ten nucleotides have been incorporated, rifampicin does not inhibit RNA synthesis. Which of the following best explains how rifampicin functions? (A)rifampicin binds only to the core enzyme when bound to DNA but can bind to the holoenzyme when not bound to DNA (B) rifampicin can bind to RNA polymerase when the polymerase is not bound to DNA but cannot bind when the polymerase is bound to DNA (C) rifampicin only inhibits when the a subunit is bound to the core enzyme (D) rifampicin is able to bind to the nucleotide binding site at any time (E) none of the above

12The carboxyl-terminal domain (CTD) of RNA polymerase II is involved in
(A) binding to promoter regions of DNA.
(B) formation of the transcription bubble.
(C) coordinating post-transcriptional processing events.
(D) recognition of the term nination signal.
(E) None of the above.

詳解 (共 1 筆)

相關試題

相關試卷